Визуализация миокарда у пациентов с гипертрофической кардиомиопатией путем вычисления Т1-карт и региональной сократительной функции с помощью магнитно-резонансной томографии.
Аннотация
Об авторе
Ольга Юрьевна ДарийРоссия
врач рентгенолог
PhD preparation
Список литературы
1. Gersh B.J., Maron B.J., Bonow R.O., et al. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, Circulation. 2011;124:2761-2796
2. Чудиновских Ю.А., Еремеева М.В., Сухачева Т.В.: Особенности морфологии и механизма патогенеза гипертрофической кардиомиопатии. Кардиология, 2011г., №2: 81-88c.
3. Ellims A.H., Iles L.M., Hare J.L., Kaye D.M., Taylor A.J. 2012: A comprehensive evaluation of myocardial fibrosis in hypertrophic cardiomyopathy with cardiac magnetic resonance imaging: linking genotype with fibrotic phenotype. Journal of Cardiovascular Magnetic Resonance, 2012, 14:76.
4. Синицын В.Е., Мершина Е.А, Першина Е.С., Благова О.В.: Редкий случай некаронарогенного ишемического поражения миокарда при гипертрофической кардиомиопатии. Лучевая диагностика, Спецвыпуск№3, 2014, 16-18с.
5. Brouwer W.P., Baars E.N., Germans T., et al.: In-vivoT1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy Journal of Cardiovascular Magnetic Resonance 2014, 16:28
6. Бокерия О.Л., Шадания Я. Р., Аверина И. И., Мироненко М.Ю., и др.: Использование показателей деформации миокарда при отборе пациентов на сердечную ресинхронизирующую терапию. Анналы аритмологии №1, 2011г, 30-34с.
7. Swoboda P.P., Larghat A., Zaman A., et al.: Comparison of magnetic resonance feature tracking for systolic and diastolic strain rate calculation with spatial modulation of magnetixation imaging analysis. J Magn Reson Imaging 2015;41:1000-12.
8. Cerqueira M.D., Weissman N.J., Dilsizian V., et al.: Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from cardiac imaging committee of the council on clinical cardiology of the american heart association. Circulation. 2002;104;1380-4
9. Donekal S., Ambale-Venkatesh B., Berkowitz S., et al.: Inter-study reproducibility of cardiovascular magnetic resonance tagging. J Cardiovasc Magn Reson. 2013;15:37.
10. Flett AS, Hayward MP, Ashworth MT, et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation. 2010;122:138–44.
11. Schelbert E.B., Messroghli D.R.: State of the Art: clinical applications of cardiac T1 mapping. Radiology. 2016;278:658–76.
12. Miller C.A., Naish J.H., Bishop P., et al.: Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging. 2013;6:373–83.
13. Watkins H., Ashrafian H., McKenna W.J., The genetics of hypertrophic cardiomyopathy: Teare redux. Heart. 2008;94(10):1264–8.
14. Перуцкий Д.Н., Макеева Т. И., Константинов С.Л. : Возможности стресс-эхокардиографии в диагностике жизнеспособного миокарда у больных с ишемической болезнью сердца. Рациональная Фармакотерапия в Кардиологии 2011;7(3), 334-341с.
15. Smith B.M., Dorfman A.L., Yu S, et al.: Clinical significance of late gadolinium enhancement in patients < 20 years of age with hypertrophic cardiomyopathy. Am J Cardiol. 2014;113:1234–9.
16. Kellman P., Arai A.E., Xue H.: T1 and extracellular volume mapping in the heart: estimation of error maps and the influence of noise on precision. J Cardiovasc Magn Reson. 2013;15:56.
17. Reference:
18. Gersh B.J., Maron B.J., Bonow R.O., et al. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, Circulation. 2011;124:2761-2796
19. Chudinovskikh Yu.a., Eremeeva M.V., Sukhacheva T.V.: Peculiarities of Morphology and Mechanisms of Pathogenesis of Hypertrophic Cardiomyopathy. Kardiologiia, 2011г., №2: 81-88pag. (in Russian).
20. Ellims A.H., Iles L.M., Hare J.L., Kaye D.M., Taylor A.J. 2012: A comprehensive evaluation of myocardial fibrosis in hypertrophic cardiomyopathy with cardiac magnetic resonance imaging: linking genotype with fibrotic phenotype. Journal of Cardiovascular Magnetic Resonance, 2012, 14:76.
21. Sinitsyn V.E., Mershina E.A., Pershina E.S., Blagova O.V.: A rare case of ischemic myocardial damage in hypertrophic cardiomyopathy. Diagnostic radiology and radiotherapy №3, 2014, 16-18pag. (in Russian)
22. Brouwer W.P., Baars E.N., Germans T., et al.: In-vivoT1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy Journal of Cardiovascular Magnetic Resonance 2014, 16:28
23. Bockeria O. L., Shadaniya Ya. R., Averina I. I., Mironenko M. Yu., Dontsova V. I., Soboleva N. N..: The usage of indices of myocardium deformation in the selection of patients for cardiac resynchronized therapy. Annaly aritmologii №1, 2011, 30-34pag. (in Russian).
24. Swoboda P.P., Larghat A., Zaman A., et al.: Comparison of magnetic resonance feature tracking for systolic and diastolic strain rate calculation with spatial modulation of magnetixation imaging analysis. J Magn Reson Imaging 2015;41:1000-12.
25. Cerqueira M.D., Weissman N.J., Dilsizian V., et al.: Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from cardiac imaging committee of the council on clinical cardiology of the american heart association. Circulation. 2002;104;1380-4
26. Donekal S., Ambale-Venkatesh B., Berkowitz S., et al.: Inter-study reproducibility of cardiovascular magnetic resonance tagging. J Cardiovasc Magn Reson. 2013;15:37.
27. Flett AS, Hayward MP, Ashworth MT, et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation. 2010;122:138–44.
28. Schelbert E.B., Messroghli D.R.: State of the Art: clinical applications of cardiac T1 mapping. Radiology. 2016;278:658–76.
29. Miller C.A., Naish J.H., Bishop P., et al.: Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging. 2013;6:373–83.
30. Watkins H., Ashrafian H., McKenna W.J., The genetics of hypertrophic cardiomyopathy: Teare redux. Heart. 2008;94(10):1264–8.
31. Perutskiy D.N., Makeeva T.I., Konstantinov S.L.: Value of stress echocardiography in diagnosis of viable myocardium in patients with ischemic heart disease. Rational Pharmacother. Card. 2011;7(3):334-342. (in Russian).
32. Smith B.M., Dorfman A.L., Yu S, et al.: Clinical significance of late gadolinium enhancement in patients < 20 years of age with hypertrophic cardiomyopathy. Am J Cardiol. 2014;113:1234–9.
33. Kellman P., Arai A.E., Xue H.: T1 and extracellular volume mapping in the heart: estimation of error maps and the influence of noise on precision. J Cardiovasc Magn Reson. 2013;15:56.
Дополнительные файлы
|
1. Визуализация миокарда у пациентов с гипертрофической кардиомиопатией путем вычисления Т1-карт и региональной сократительной функции с помощью магнитно-резонансной томографии | |
| Тема | Ключевые слова: магнитно-резонансная томография, ГКМП, Т1-карты, MOLLI, ECV, деформация миокарда. | |
| Тип | Исследовательские инструменты | |
Скачать
(30KB)
|
Метаданные | |
Рецензия
Для цитирования:
Дарий О.Ю. Визуализация миокарда у пациентов с гипертрофической кардиомиопатией путем вычисления Т1-карт и региональной сократительной функции с помощью магнитно-резонансной томографии. Вестник рентгенологии и радиологии. 2018;99(2). https://doi.org/10.20862/0042-4676-2018-99-2-
Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial» («Атрибуция — Некоммерческое использование») 3.0 Непортированная
Послать статью по эл. почте 